These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Preparation of cucurbitacinBE polylactic acid nano-particles for targeting cervical lymph nodes]. Yang K; Wen Y; Li L; Wang C; Hou S; Li C Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Dec; 19(6):347-50. PubMed ID: 12539678 [TBL] [Abstract][Full Text] [Related]
7. Particle characteristics and lung deposition patterns in a human airway replica of a dry powder formulation of polylactic acid produced using supercritical fluid technology. Cheng YS; Yazzie D; Gao J; Muggli D; Etter J; Rosenthal GJ J Aerosol Med; 2003; 16(1):65-73. PubMed ID: 12737686 [TBL] [Abstract][Full Text] [Related]
8. Functionalized PLA polymers to control loading and/or release properties of drug-loaded nanoparticles. Thauvin C; Schwarz B; Delie F; Allémann E Int J Pharm; 2018 Sep; 548(2):771-777. PubMed ID: 29104059 [TBL] [Abstract][Full Text] [Related]
9. Colchicine encapsulation within poly(ethylene glycol)-coated poly(lactic acid)/poly(epsilon-caprolactone) microspheres-controlled release studies. Das GS; Rao GH; Wilson RF; Chandy T Drug Deliv; 2000; 7(3):129-38. PubMed ID: 10989913 [TBL] [Abstract][Full Text] [Related]
10. Polylactic acid nanoparticles targeted to brain microvascular endothelial cells. Wang H; Hu Y; Sun W; Xie C J Huazhong Univ Sci Technolog Med Sci; 2005; 25(6):642-4. PubMed ID: 16696313 [TBL] [Abstract][Full Text] [Related]
11. Active targeting behaviors of biotinylated pluronic/poly(lactic acid) nanoparticles in vitro through three-step biotin-avidin interaction. Xiong XY; Gong YC; Li ZL; Li YP; Guo L J Biomater Sci Polym Ed; 2011; 22(12):1607-19. PubMed ID: 20699057 [TBL] [Abstract][Full Text] [Related]
12. Chitosan/PLA nanoparticles as a novel carrier for the delivery of anthraquinone: synthesis, characterization and in vitro cytotoxicity evaluation. Jeevitha D; Amarnath K Colloids Surf B Biointerfaces; 2013 Jan; 101():126-34. PubMed ID: 22796782 [TBL] [Abstract][Full Text] [Related]
13. Drug delivery across intact and disrupted skin barrier: Identification of cell populations interacting with penetrated thermoresponsive nanogels. Rancan F; Giulbudagian M; Jurisch J; Blume-Peytavi U; Calderón M; Vogt A Eur J Pharm Biopharm; 2017 Jul; 116():4-11. PubMed ID: 27865989 [TBL] [Abstract][Full Text] [Related]
14. Atovaquone-loaded nanocapsules: influence of the nature of the polymer on their in vitro characteristics. Cauchetier E; Deniau M; Fessi H; Astier A; Paul M Int J Pharm; 2003 Jan; 250(1):273-81. PubMed ID: 12480292 [TBL] [Abstract][Full Text] [Related]
15. Nimesulide PLA microspheres as a potential sustained release system for the treatment of inflammatory diseases. Freitas MN; Marchetti JM Int J Pharm; 2005 May; 295(1-2):201-11. PubMed ID: 15848005 [TBL] [Abstract][Full Text] [Related]
16. Innovative drug vehicle for local treatment of inflammatory skin diseases: Ex vivo and in vivo screening of five topical formulations containing poly(lactic acid) (PLA) nanoparticles. Boisgard AS; Lamrayah M; Dzikowski M; Salmon D; Kirilov P; Primard C; Pirot F; Fromy B; Verrier B Eur J Pharm Biopharm; 2017 Jul; 116():51-60. PubMed ID: 27702687 [TBL] [Abstract][Full Text] [Related]
18. Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel. Xie J; Wang CH Pharm Res; 2005 Dec; 22(12):2079-90. PubMed ID: 16132339 [TBL] [Abstract][Full Text] [Related]
19. Design of biodegradable particles for protein delivery. Vila A; Sánchez A; Tobío M; Calvo P; Alonso MJ J Control Release; 2002 Jan; 78(1-3):15-24. PubMed ID: 11772445 [TBL] [Abstract][Full Text] [Related]
20. Physicochemical characterization of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) nanoparticles with polyethylenimine as gene delivery carrier. Kim IS; Lee SK; Park YM; Lee YB; Shin SC; Lee KC; Oh IJ Int J Pharm; 2005 Jul; 298(1):255-62. PubMed ID: 15941631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]